TY - JOUR
T1 - Effects of long-term treatment with dicyclic, tricyclic, tetracyclic, and noncyclic antidepressant drugs on monoamine oxidase activity in mouse brain
AU - Egashira, Toru
AU - Takayama, Fusako
AU - Yamanaka, Yasumitsu
PY - 1996/7
Y1 - 1996/7
N2 - 1. The individual long term effects of the antidepressant drugs zimeldine, viloxazine, imipramine, amitriptyline, nortriptyline, maprotiline, or nomifensine, on brain mitochondrial monoamine oxidase (MAO) activity, were studied in mice that were given daily intraperitoneal injections (30 mg/kg) of these reagents for 4 weeks. 2. Both the A form (MAO-A) and B-form (MAO-B) of MAO were inhibited after long-term administration of all the drugs except nortriptyline (MAO-A was not affected) and maprotiline (neither MAO-A nor MAO-B were affected). 3. Kinetic analysis showed a significant decrease in V(max) values, and an increase in K(m) values for MAO-B during treatment. 4. All seven drugs are competitive inhibitors of MAO-A, noncompetitive inhibitors of MAO-B, and were more potent in vitro for MAO-B. 5. MAO-A was inhibited by the following drugs (in ascending order of potency): nortriptyline, amitriptyline, imipramine, maprotiline, zimeldine, nomifensine, and viloxazine. 6. MAO-B was inhibited by the following drugs (in ascending order of potency): nortriptyline, imip ramine, maprotilinel amitriptyline, zimelaine, nomifensine, and viloxazine.
AB - 1. The individual long term effects of the antidepressant drugs zimeldine, viloxazine, imipramine, amitriptyline, nortriptyline, maprotiline, or nomifensine, on brain mitochondrial monoamine oxidase (MAO) activity, were studied in mice that were given daily intraperitoneal injections (30 mg/kg) of these reagents for 4 weeks. 2. Both the A form (MAO-A) and B-form (MAO-B) of MAO were inhibited after long-term administration of all the drugs except nortriptyline (MAO-A was not affected) and maprotiline (neither MAO-A nor MAO-B were affected). 3. Kinetic analysis showed a significant decrease in V(max) values, and an increase in K(m) values for MAO-B during treatment. 4. All seven drugs are competitive inhibitors of MAO-A, noncompetitive inhibitors of MAO-B, and were more potent in vitro for MAO-B. 5. MAO-A was inhibited by the following drugs (in ascending order of potency): nortriptyline, amitriptyline, imipramine, maprotiline, zimeldine, nomifensine, and viloxazine. 6. MAO-B was inhibited by the following drugs (in ascending order of potency): nortriptyline, imip ramine, maprotilinel amitriptyline, zimelaine, nomifensine, and viloxazine.
KW - Antidepressants
KW - MAO-A
KW - MAO-B
KW - Mouse brain
UR - http://www.scopus.com/inward/record.url?scp=0030198957&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030198957&partnerID=8YFLogxK
U2 - 10.1016/0306-3623(95)02126-4
DO - 10.1016/0306-3623(95)02126-4
M3 - Article
C2 - 8842678
AN - SCOPUS:0030198957
SN - 1537-1891
VL - 27
SP - 773
EP - 778
JO - Vascular Pharmacology
JF - Vascular Pharmacology
IS - 5
ER -